Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)

Clinical trial NCT00268879 · COMPLETED

Trial details

NCT number: NCT00268879
Sponsor: Alizyme
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Irritable Bowel Syndrome

Start date: 2005-12-01
Primary completion: 2008-01-01
Enrollment: 1821

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.